Germany has recently announced that it will not offer the AstraZeneca COVID-19 jab to over-65s due to insufficient data about its efficacy in that age group. Meanwhile, initial data from Israel seemed to suggest that 14 days after the Pfizer/BioNTech…
Read More
Covid vaccine update: Delaying second dose may boost effectiveness, says JCVI expert
Matt Hancock says there could be annual coronavirus vaccine The government has faced backlash over the last couple of days following its decision to distribute only the first dose of vaccines that require two shots to confer maximum protection. The…
Read More
Mexico approves AstraZeneca vaccine for emergency use
Mexico approved the Oxford-AstraZeneca coronavirus vaccine for emergency use Monday, hoping to spur a halting vaccination effort that has only given about 44,000 shots since the third week of December, about 82% of the doses the country has received. The…
Read More
AstraZeneca buying drug developer Alexion for $39 billion
Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion. Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to develop a COVID-19 vaccine, said Saturday it’s using a combination…
Read More
AstraZeneca, J&J vaccine trials back on track in US
Two major clinical trials for experimental COVID-19 vaccines got back on track in the United States Friday—providing a glimmer of hope as the number of cases skyrocket across the country. COVID-19 has now killed more than 223,000 Americans, and the…
Read More
Why AstraZeneca and others racing to make a COVID-19 vaccine should be more open about the process
AstraZeneca is resuming clinical trials for the COVID-19 vaccine, ChAdOx1 nCoV-19, following confirmation that is safe to do so. The trials were paused when one of the participants developed an “unexplained illness.” The pause is over, but the concerns that…
Read More